🔎 Trials Near Me

Home › Overweight › Tennessee › Knoxville

Overweight clinical trials in Knoxville, TN

7 studies for Overweight are looking for participants at sites in and around Knoxville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RecruitingPhase 2
  • New Phase Research & Development /ID# 282131, Knoxville
  • Summit Medical Group- Halls Family Physicians /ID# 282435, Knoxville
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07752979

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RecruitingPhase 3
  • New Phase Research and Development, Knoxville
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

RecruitingPhase 3
  • Research Site, Knoxville
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RecruitingPhase 3
  • Accellacare of Knoxville, Knoxville
  • Cardiovascular Research of Knoxville North Knoxville Medical Center, Powell · 8 mi away
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RecruitingPhase 3
  • New Phase Research and Development, Knoxville
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684235

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

RecruitingPhase 3
  • ACCOMPLISH-1 Research Site, Knoxville
Ages 18 to 79 · All sexes · Updated Aug 10, 2026 · NCT07654361

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

RecruitingPhase 1
  • MBX Biosciences Investigational Site, Knoxville
Ages 18 to 65 · All sexes · Updated Jun 9, 2026 · NCT07142707

Overweight trials in other cities

Other studies in Knoxville

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.